Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of T in PBMC and TILs

ABSTRACT: RNA-seq of T in PBMC and TILs

PROVIDER: PRJNA663398 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12639948_1.fastq.gz	Fastqsanger.gz
	SRR12639948_2.fastq.gz	Fastqsanger.gz
	SRR12639949_1.fastq.gz	Fastqsanger.gz
	SRR12639949_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

RNA-seq of T in PBMC and TILs

Project description:Purpose: Transcriptome profiling (RNA-seq) was used to compare the expression differences between T in PBMC and TILs Methods:Paired TILs and T in PBMC cells were sorted from fresh patient blood and tumor samples. Then the mRNA were sequeced using xTen platform. The sequence reads that passed quality filters were analyzed. Results: by extract mRNA from tumor infiltrated T cells from ovarian cancer patient sample and T cells from patient bllod samples, we compared the different expressed genes from TIL and T in blood. Hierarchical clustering of differentially expressed genes uncovered several as yet uncharacterized genes that may contribute to T cell exhausetion. Conclusions: We conclude that T in PBMC and TILs share different transcriptome characterization.

2022-12-18 | GSE157936 | GEO

SLE PBMC RNA-seq

Project description:SLE PBMC RNA-seq

| PRJNA505280 | ENA

PBMC RNA-seq

Project description:PBMC RNA-seq

2021-05-16 | OEX00003863 | NODE

Single Cell RNA-seq on Human PBMC

Project description:Single Cell RNA-seq on Human PBMC

| PRJNA834020 | ENA

RNA-seq analysis of gene expression regulated by LSD1 in CD8+ TILs

Project description:RNA-seq analysis of gene expression regulated by LSD1 in CD8+ TILs

| PRJNA613073 | ENA

Gene expression differences between TILs that are reactive to tumor cells and TILs that are not reactive

Project description:Clinical significance of tumor-infiltrating lymphocytes (TILs) was demonstrated in many tumor types. In the clinical trials, immune check point inhibitors showed significant clinical efficacy in some tumor types with high mutation burden such as melanoma, bladder cancer, and smoking-induced lung cancer, while there were little effects in cancers with lower mutation rates such as breast cancer. Recently, selection and adoptive transfer of autologous mutation-specific TILs showed successful regression of metastatic tumors in an estrogen receptor-positive breast cancer patient. In this study, we analyzed gene expression profiles in cultured TILs that are reactive or non reactive against autologous breast cancer cells. We cultured TILs and cancer cells derived from breast tumor tissues obtained from the surgery. Reactivity of TILs against cancer cells was determined by interferon gamma (IFN-γ) ELISA analysis after co-culture of TILs and cancer cells for 24 hours. The total RNA was purified from cultured TILs (post-REP TILs) using RNeasy kits. The gene expression library is generated by Illumina TruSeq RNA library prep kit and sequenced.

2025-06-30 | GSE252437 | GEO

RNA-Seq Analysis

Project description:RNA-Seq analysis carried out in three different backcrosses based on Iberian breed with Landrace, Pietrain and Duroc breeds

2017-10-31 | PRJEB23068 | EVA

RNA-seq of HIV bnAb and control individuals PBMC

Project description:RNA-seq of HIV bnAb and control individuals PBMC

| PRJNA475036 | ENA

scRNA-seq of bovine PBMC

Project description:scRNA-seq of bovine PBMC

| PRJEB50632 | ENA

RNA-sequencing of melanoma-derived tumor-infiltrating lymphocytes (TILs)

Project description:RNA-sequencing of melanoma-derived tumor-infiltrating lymphocytes (TILs)